Pharmacists can fill a gap in care by expanding their injectable medication administration services beyond immunization, according to a report published online in the Journal of the American Pharmacists Association. The report summarizes the outcomes of APhA’s Stakeholder Conference on Improving Patient Access to Injectable Medications.
Last December, representatives from community-based pharmacy practices, health systems, specialty pharmacy, and national and state pharmacy organizations came together to discuss how pharmacists can enhance outcomes for patients on injectable medication therapies for conditions such as allergies, cardiovascular disease, rheumatoid arthritis, and schizophrenia. Conference participants identified current challenges in providing injectable medication services in the pharmacy environment, including laws and regulations, payer recognition, and education and training, as well as patient care challenges like care coordination and care management.
To address these challenges, participants called for the profession to develop and disseminate policy statements and practice guidance, and to integrate national, standardized education and training in schools of pharmacy and continuing pharmacy education. Other recommendations included practice-level tools and resources and enhanced technology solutions. All told, the conference generated more than 150 strategies for how the profession can establish pharmacists as providers of injectable medications within community-based pharmacy practice.